Is the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain & #8211;Barre syndrome following the first dose ?

Josef FinstererIndian Journal of Public Health 2022 66(3):385-386

https://www.ijph.in/text.asp?2022/66/3/385/356584

Source: Indian Journal of Public Health - September 22, 2022 Category: International Medicine & Public Health Authors: Josef Finsterer Source Type: research

More News: Guillain-Barr Syndrome | India Health | International Medicine & Public Health | SARS | Vaccines